Home
About
Company Profile
Directorate
Vision and Mission
Sponsorships
Facts
Awards
Divisions
Distribution Centres
Partners
Brand Ambassadors
News
Products
OTC Products
Scheduled Products
Media Centre
Press Releases
Video Library
CSI
Careers
Why work at Cipla
Jobs
Contact Us
Visit Cipla Investor Website
Over-the-counter products
Scheduled Products
Anthelmintics
Antibiotics
Antidiabetics
Antifungals
Antimalarials
Antivirals
ARVs
Cardiovascular
Gastrointestinal
Gynaecological
Hormone Inhibitors
Neuropsychiatry
NSAIDS / Analgesics
Oncology
Ophthalmic
Osteoporosis
Respiratory / Allergy
Topicals
Urological
Bicadex 50 Tablets
Reg. No. A40/21.12/0304
S4
Bicalutamide 50 mg
Pack: 30's
oncology
Package Insert
Cipla-Docetaxel 20 / 80
Reg. No. S4 41/26/0162, 0163; S1 44/32.2/0393, 0394
Solution for infusion & Solvent for injection
Solution for infusion: Docetaxel Trihydrate 20 mg / 80 mg
Solvent for injection: 13,0 % m/v Ethanol 95 % v/v
Pack: 5 ml, 15 ml vials
oncology
Package Insert
Cipla-Irinotecan 40 / 100
Reg. No. 41/26/0049, 0050
S4
Solution for infusion
Irinotecan HCI Trihydrate 40 mg / 2 ml
Irinotecan HCI Trihydrate 100 mg / 5 ml
Pack: 2 ml, 5 ml vials
oncology
Package Insert
Cipla-Paclitaxel 30 / 100 / 300
Reg. No. 41/26/0423, 0424, 0425
S4
Concentrate for dilution for infusion
Paclitaxel 30 ml / 5 ml
Paclitaxel 100 mg / 16.7 ml
Paclitaxel 300 mg / 50 ml
Pack: 5 ml, 20 ml, 50 ml vials
oncology
Package Insert
Cipla-Vinorelbine 10 / 50
Reg. No. 42/26/0083, 84
S4
Intravenous injection
Vinorelbine 10 mg / 1 ml
Vinorelbine 50 mg / 5 ml
Pack: 2 ml, 5 ml vials
oncology
Package Insert
Granicip 1 mg & 2 mg Tablets
Reg. No. 41/5.7.2/0397, 0398
S4
Film-coated Tablets
Granisetron 1 mg & 2 mg
Pack: 5's, 10's
oncology
Package Insert
CIPLA-CYPROTERONE ACETATE 50 Tablets
Reg. No. 35/21.12/0293
S4
Cyproterone acetate 50 mg
Pack: 20's
oncology
Package Insert
Cipla-Ondansetron
Reg. No. A38/5.10/0435, 0436
S4
Ondansetron 4 mg & 8 mg
Pack: 10's
Package Insert
Back to top